{"id":2014,"date":"2022-01-17T14:48:04","date_gmt":"2022-01-17T13:48:04","guid":{"rendered":"http:\/\/invivo.partners\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"},"modified":"2025-10-28T18:36:15","modified_gmt":"2025-10-28T17:36:15","slug":"difficult-indications-pancreatic-cancer","status":"publish","type":"post","link":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","title":{"rendered":"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS"},"content":{"rendered":"<p>Cuanto mayor es la necesidad cl\u00ednica y la prevalencia, mayor es el esfuerzo de los cient\u00edficos de todo el mundo por intentar resolver un problema.<br \/>\nEl adenocarcinoma ductal de p\u00e1ncreas (PDAC) sigue siendo hoy una de las mayores necesidades cl\u00ednicas no resueltas. Es una enfermedad devastadora con un pron\u00f3stico desfavorable y se prev\u00e9 que se convierta en el segundo c\u00e1ncer m\u00e1s mortal para 2030.<br \/>\nActualmente, la tasa de supervivencia global a 5 a\u00f1os es inferior al 10%, a pesar de todos los esfuerzos realizados.<\/p>\n<p>Sin embargo, cada mes surgen nuevas terapias, y el ritmo de innovaci\u00f3n en este campo es extraordinario.<\/p>\n<p>Todas las grandes necesidades cl\u00ednicas no resueltas pueden representar una buena oportunidad de inversi\u00f3n.<br \/>\nAqu\u00ed tienes un mapa conceptual (no exhaustivo) con algunas de las alternativas y dianas m\u00e1s innovadoras que se est\u00e1n desarrollando.<br \/>\nUn mapa para orientarse en el panorama y evitar perderse entre las diferentes categor\u00edas y enfoques.<\/p>\n<p>Puedes encontrar todas mis quick notes en<span class=\"break-words\"><span dir=\"ltr\"> <a href=\"https:\/\/www.linkedin.com\/feed\/hashtag\/?keywords=quick_notes_lp&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6888746902037307392\" data-attribute-index=\"0\">#quick_notes_LP<\/a><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cuanto mayor es la necesidad cl\u00ednica y la prevalencia, mayor es el esfuerzo de los cient\u00edficos de todo el mundo por intentar resolver un problema. El adenocarcinoma ductal de p\u00e1ncreas (PDAC) sigue siendo hoy una de las mayores necesidades cl\u00ednicas no resueltas. Es una enfermedad devastadora con un pron\u00f3stico desfavorable y se prev\u00e9 que se<\/p>\n","protected":false},"author":1,"featured_media":2011,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[584],"tags":[],"class_list":["post-2014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ideas-lab"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Cuanto mayor es la necesidad cl\u00ednica y la prevalencia, mayor es el esfuerzo de los cient\u00edficos de todo el mundo por intentar resolver un problema. El adenocarcinoma ductal de p\u00e1ncreas (PDAC) sigue siendo hoy una de las mayores necesidades cl\u00ednicas no resueltas. Es una enfermedad devastadora con un pron\u00f3stico desfavorable y se prev\u00e9 que se\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-17T13:48:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T17:36:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/invivo.partners\/wp-content\/uploads\/2022\/01\/DIFFICULT-INDICATIONS-PANCREATIC-CANCER.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"999\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"invivo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"invivo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\"},\"author\":{\"name\":\"invivo\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\"},\"headline\":\"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS\",\"datePublished\":\"2022-01-17T13:48:04+00:00\",\"dateModified\":\"2025-10-28T17:36:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\"},\"wordCount\":180,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Ideas Lab\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\",\"url\":\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\",\"name\":\"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2022-01-17T13:48:04+00:00\",\"dateModified\":\"2025-10-28T17:36:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\",\"name\":\"invivo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"caption\":\"invivo\"},\"url\":\"https:\/\/invivo.partners\/es\/author\/invivocapital\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","og_locale":"es_ES","og_type":"article","og_title":"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS - Invivo Partners","og_description":"Cuanto mayor es la necesidad cl\u00ednica y la prevalencia, mayor es el esfuerzo de los cient\u00edficos de todo el mundo por intentar resolver un problema. El adenocarcinoma ductal de p\u00e1ncreas (PDAC) sigue siendo hoy una de las mayores necesidades cl\u00ednicas no resueltas. Es una enfermedad devastadora con un pron\u00f3stico desfavorable y se prev\u00e9 que se","og_url":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","og_site_name":"Invivo Partners","article_published_time":"2022-01-17T13:48:04+00:00","article_modified_time":"2025-10-28T17:36:15+00:00","og_image":[{"width":800,"height":999,"url":"https:\/\/invivo.partners\/wp-content\/uploads\/2022\/01\/DIFFICULT-INDICATIONS-PANCREATIC-CANCER.jpg","type":"image\/jpeg"}],"author":"invivo","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"invivo","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"},"author":{"name":"invivo","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789"},"headline":"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS","datePublished":"2022-01-17T13:48:04+00:00","dateModified":"2025-10-28T17:36:15+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"},"wordCount":180,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Ideas Lab"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","url":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","name":"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2022-01-17T13:48:04+00:00","dateModified":"2025-10-28T17:36:15+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/es\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/es\/"},{"@type":"ListItem","position":2,"name":"INDICACIONES DIF\u00cdCILES: C\u00c1NCER DE P\u00c1NCREAS"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789","name":"invivo","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","caption":"invivo"},"url":"https:\/\/invivo.partners\/es\/author\/invivocapital\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/2014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/comments?post=2014"}],"version-history":[{"count":3,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/2014\/revisions"}],"predecessor-version":[{"id":3940,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/posts\/2014\/revisions\/3940"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media\/2011"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/media?parent=2014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/categories?post=2014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/es\/wp-json\/wp\/v2\/tags?post=2014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}